Skip to main content
Home > Week in Review > Management

Chronological Index of : Management Tracks

 Current Issue
  • Amarantus Bioscience management update

    Amarantus Bioscience Holdings Inc. (OTCQB:AMBS), San Francisco, Calif. Business: Neurology, Cardiovascular Hired: Charlotte Keywood as CMO of Amarantus' therapeutics division, formerly CMO of Addex Therapeutics Ltd.

    Published on 4/14/2014
  • Atara Biotherapeutics management update

    Atara Biotherapeutics Inc., Brisbane, Calif. Business: Cancer, Renal Hired: Mitchall Clark as chief regulatory and quality assurance officer, formerly EVP and CFO of Onyx Pharmaceuticals Inc., which Amgen Inc. acquired

    Published on 4/14/2014
  • AthernoNova management update

    AtheroNova Inc. (OTCBB:AHRO), Irvine, Calif. Business: Cardiovascular Hired: Randolph Johnson as COO, formerly chief of technology development and VP of research at KAI Pharmaceuticals Inc., which Amgen Inc. acquired

    Published on 4/14/2014
  • Biogen Idec management update

    Biogen Idec Inc. (NASDAQ:BIIB), Weston, Mass. Business: Biopharmaceuticals Hired: Adam Koppel as SVP and chief strategy officer, a newly created role, effective May 15, formerly a managing director at Brookside Capital,…

    Published on 4/14/2014
  • Cequr management update

    Cequr S.A., Montreux, Switzerland Business: Endocrine/Metabolic, Drug delivery Hired: Douglas Lawrence as CEO, formerly VP for the insulin injection business at Becton Dickinson and Co.; he succeeds James Peterson, who …

    Published on 4/14/2014
  • Chimerix management update

    Chimerix Inc. (NASDAQ:CMRX), Durham, N.C. Business: Infectious Resigned: Kenneth Moch as president and CEO; he is succeeded by CMO Michelle Beery

    Published on 4/14/2014
  • Convoy Therapeutics management update

    Convoy Therapeutics Inc., Oro Valley, Ariz. Business: Dermatology Hired: Mary Spellman as CMO, formerly CMO of Revance Therapeutics Inc.

    Published on 4/14/2014
  • Deciphera management update

    Deciphera Pharmaceuticals LLC, Lawrence, Kan. Business: Cancer Hired: Michael Taylor as president, CEO and a director, formerly CEO of Ensemble Therapeutics Corp.; he succeeds Daniel Flynn, who becomes CSO and remains a…

    Published on 4/14/2014
  • e-Therapeutics management update

    e-Therapeutics plc (LSE:ETX), Newcastle upon Tyne, U.K. Business: Infectious, Cancer Hired: Steve Medlicott as finance director

    Published on 4/14/2014
  • Elusys management update

    Elusys Therapeutics Inc., Pine Brook, N.J. Business: Antibodies, Infectious, Autoimmune Hired: Lawrence Gyenes as CFO, formerly CFO of Columbia Laboratories Inc.

    Published on 4/14/2014
  • Gen9 management update

    Gen9 Inc., Cambridge, Mass. Business: Genomics, Supply/Service Hired: Jennifer Camacho as chief legal officer and business counsel, a newly created role, formerly a partner at Greenberg Traurig LLP

    Published on 4/14/2014
  • Genocea management update

    Genocea Biosciences Inc. (NASDAQ:GNCA), Cambridge, Mass. Business: Infectious Hired: Jonathan Poole as CFO, formerly SVP of finance for pipeline and technical operations at Shire plc

    Published on 4/14/2014
  • GTx management update

    GTx Inc. (NASDAQ:GTXI), Memphis, Tenn. Business: Cancer, Musculoskeletal Transitioned: President and COO Marc Hanover to interim CEO and a director; he replaces Mitchell Steiner, who will also step down as vice chairman

    Published on 4/14/2014
  • HTG Molecular Diagnostics management update

    HTG Molecular Diagnostics Inc., Tucson, Ariz. Business: Genomics, Supply/Service, Diagnostic Hired: Patrick Roche as SVP for in vitro diagnostic assay development, formerly VP of translational diagnostics at Roche's …

    Published on 4/14/2014
  • Icon Bioscience management update

    Icon Bioscience Inc., Sunnyvale, Calif. Business: Ophthalmic Hired: David Tierney as president and CEO, formerly president and COO of Oceana Therapeutics Inc., which Salix Pharmaceuticals Inc. acquired

    Published on 4/14/2014
  • MediciNova management update

    MediciNova Inc. (NASDAQ:MNOV; JASDAQ:4875), San Diego, Calif. Business: Genitourinary, Inflammation, Neurology Hired: Esther van den Boom as CFO, formerly a senior manager at Ernst & Young LLP; she replaces President …

    Published on 4/14/2014
  • MEI Pharma management update

    MEI Pharma Inc. (NASDAQ:MEIP), San Diego, Calif. Business: Cancer Hired: David Urso as SVP of corporate development and general counsel, formerly COO and general counsel at Tioga Pharmaceuticals Inc.

    Published on 4/14/2014
  • Mela Sciences management update

    Mela Sciences Inc. (NASDAQ:MELA), Irvington, N.Y. Business: Diagnostic Hired: Robert Cook as CFO, formerly SVP and CFO of Immune Pharmaceuticals Inc.

    Published on 4/14/2014
  • Novartis management update

    Novartis AG (NYSE:NVS; SIX:NOVN), Basel, Switzerland Business: Pharmaceuticals Hired: Richard Francis as division head of Novartis' Sandoz International GmbH generics unit, effective May 1, formerly SVP of U.S. …

    Published on 4/14/2014
  • Novavax management update

    Novavax Inc. (NASDAQ:NVAX), Rockville, Md. Business: Infectious Hired: Cynthia Oliver as SVP of process development operations, formerly VP of process biochemistry and formulation sciences at the MedImmune LLC biologics…

    Published on 4/14/2014
  • NuCana BioMed board of directors update

    NuCana Biomed Ltd., Edinburgh, U.K. Business: Cancer Appointed: Gerald Chan, co-founder and chairman at Morningside Ventures; and James Healy, general partner at Sofinnova Ventures

    Published on 4/14/2014
  • Piqur board of directors update

    Piqur Therapeutics AG, Basel, Switzerland Business: Cancer Appointed: Guido Magni, venture partner at Versant Ventures

    Published on 4/14/2014
  • RefleXion Medical board of directors update

    RefleXion Medical Inc., Burlingame, Calif. Business: Cancer Appointed: Bill Burkoth, executive director at Pfizer Venture Investments; Colin Cahill, a VP at Venrock; and Antoine Papiernik, managing partner at Sofinnova …

    Published on 4/14/2014
  • Sorrento management update

    Sorrento Therapeutics Inc. (NASDAQ:SRNE), San Diego, Calif. Business: Cancer, Antibodies Hired: Ian Walters as SVP of translational medicine and corporate development

    Published on 4/14/2014
  • Spinifex board of directors update

    Spinifex Pharmaceuticals Pty. Ltd., South Yarra, Australia Business: Neurology Appointed: Brent Ahrens, general partner at Canaan Partners; Steve Collins, formerly president and CEO of NeuroTherapeutics Pharma Inc.; and…

    Published on 4/14/2014

< Previous   1  2  3  4  5  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993